Literature DB >> 19819435

Multivariate analysis of the association between oocyte donor characteristics, including basal follicle stimulating hormone (FSH) and age, and IVF cycle outcomes.

Sara E Barton1, Stacey A Missmer, Rachel K Ashby, Elizabeth S Ginsburg.   

Abstract

OBJECTIVE: To determine whether oocyte donor FSH and age are independently associated IVF cycle success.
DESIGN: Retrospective cohort study.
SETTING: University hospital-based IVF clinic. PATIENT(S): Three hundred twelve donor/recipient pairs undergoing oocyte donation IVF. MAIN OUTCOME MEASURE(S): Number of mature oocytes and embryos, clinical pregnancy, and live birth rates. RESULT(S): Donors' basal FSH levels were not associated with IVF cycle outcomes. However, for every year increase in donor age, the number of mature oocytes decreased by 0.39 and the number of embryos decreased by 0.25 resulting in 1 less embryo for each 4-year increase in age, even in young donors. For every 100 pg/mL increase in estradiol on the day of hCG administration, the number of mature oocytes increased by 0.49 and the number of embryos increased by 0.36. For each additional 75 IU of gonadotropin used during stimulation, the likelihood of pregnancy and live birth decreased by 3.5%. CONCLUSION(S): Donor oocyte IVF cycle outcomes were not associated with donor basal FSH. However, donor age and estradiol level on the day of hCG administration were significantly associated with numbers of mature oocytes and embryos obtained, and the amount of gonadotropin used in the stimulation was significantly associated with the likelihood of pregnancy and live birth. Copyright (c) 2010 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19819435     DOI: 10.1016/j.fertnstert.2009.07.1672

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  6 in total

1.  Is younger better? Donor age less than 25 does not predict more favorable outcomes after in vitro fertilization.

Authors:  Leigh A Humphries; Laura E Dodge; Erin B Kennedy; Kathryn C Humm; Michele R Hacker; Denny Sakkas
Journal:  J Assist Reprod Genet       Date:  2019-06-10       Impact factor: 3.412

2.  Histone demethylase KDM4A and KDM4B expression in granulosa cells from women undergoing in vitro fertilization.

Authors:  Adam J Krieg; Sarah R Mullinax; Frances Grimstad; Kaitlin Marquis; Elizabeth Constance; Yan Hong; Sacha A Krieg; Katherine F Roby
Journal:  J Assist Reprod Genet       Date:  2018-03-14       Impact factor: 3.412

3.  Total number of oocytes and zygotes are predictive of live birth pregnancy in fresh donor oocyte in vitro fertilization cycles.

Authors:  Eduardo Hariton; Keewan Kim; Sunni L Mumford; Marissa Palmor; Pietro Bortoletto; Eden R Cardozo; Anatte E Karmon; Mary E Sabatini; Aaron K Styer
Journal:  Fertil Steril       Date:  2017-06-07       Impact factor: 7.329

4.  Anti-Müllerian hormone serum level and other markers associated with pregnancy outcome in oocyte donation.

Authors:  Anne-Sophie Delesalle; Geoffroy Robin; Patricia Thomas-Desrousseaux; Didier Dewailly; Sophie Catteau-Jonard
Journal:  Reprod Biol Endocrinol       Date:  2016-01-19       Impact factor: 5.211

5.  Predictive factors for successful pregnancy in an egg-sharing donation program.

Authors:  Daniela Paes de Almeida Ferreira Braga; Amanda Souza Setti; Assumpto Iaconelli; Edson Borges
Journal:  JBRA Assist Reprod       Date:  2020-05-01

6.  Multivariate analysis of oocyte donor and recipient factors affecting cumulative live birth rate in oocyte donor IVF (OD-IVF) cycles.

Authors:  Neena Malhotra; Monica Gupta; Anshu Yadav; Parul Jaiswal; Reeta Bansiwal; Neeta Singh; Ashish Datt Upadhyay; Ashok Bhatt; Reeta Mahey
Journal:  JBRA Assist Reprod       Date:  2021-10-04
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.